Clinical Trial Update: Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen [Phase 3]

View source ↗

Summary

Phase 3 trial assessing in-home use of evolocumab via prefilled syringe or autoinjector; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Mixed Dyslipidemia

Drugs mentioned

• Evolocumab (evolocumab)

Snippet

Sponsor: Amgen | Conditions: Primary Hypercholesterolemia, Mixed Dyslipidemia | Phase 3 | Status: COMPLETED | Results posted: 2015-10-09